Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 12

Results: 15

Targeting CTCFL/BORIS for the immunotherapy of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1955, doi. 10.1007/s00262-018-2251-8

By:

Loukinov, Dmitri

Publication type:

Article

The role of CCR5 in directing the mobilization and biological function of CD11b+Gr1+Ly6Clow polymorphonuclear myeloid cells in cancer.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1949, doi. 10.1007/s00262-018-2245-6

By:

Karin, Nathan;
Razon, Hila

Publication type:

Article

Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1845, doi. 10.1007/s00262-018-2244-7

By:

Zelba, Henning;
Bochem, Jonas;
Pawelec, Graham;
Garbe, Claus;
Wistuba-Hamprecht, Kilian;
Weide, Benjamin

Publication type:

Article

Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1833, doi. 10.1007/s00262-018-2241-x

By:

Dobry, Allison S.;
Zogg, Cheryl K.;
Hodi, F. Stephen;
Smith, Timothy R.;
Ott, Patrick A.;
Iorgulescu, J. Bryan

Publication type:

Article

Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC).

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1825, doi. 10.1007/s00262-018-2239-4

By:

Schmid, Sabine;
Diem, Stefan;
Li, Qiyu;
Krapf, Mirjam;
Flatz, Lukas;
Leschka, Sebastian;
Desbiolles, Lotus;
Klingbiel, Dirk;
Jochum, Wolfram;
Früh, Martin

Publication type:

Article

A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1853, doi. 10.1007/s00262-018-2236-7

By:

Gray, Jhanelle E.;
Chiappori, Alberto;
Williams, Charlie C.;
Tanvetyanon, Tawee;
Haura, Eric B.;
Creelan, Ben C.;
Kim, Jongphil;
Boyle, Theresa A.;
Pinder-Schenck, Mary;
Khalil, Farah;
Altiok, Soner;
Devane, Rebecca;
Noyes, David;
Mediavilla-Varela, Melanie;
Smilee, Renee;
Hopewell, Emily L.;
Kelley, Linda;
Antonia, Scott J.

Publication type:

Article

Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1815, doi. 10.1007/s00262-018-2235-8

By:

Yang, Chao;
Cheng, He;
Zhang, Yiyin;
Fan, Kun;
Luo, Guopei;
Fan, Zhiyao;
Huang, Qiuyi;
Lu, Yu;
Jin, Kaizhou;
Wang, Zhengshi;
Yu, Xianjun;
Liu, Chen

Publication type:

Article

Dendritic cell trafficking in tumor-bearing mice.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1939, doi. 10.1007/s00262-018-2187-z

By:

Krzastek, Sarah C.;
Goliadze, Ekaterine;
Zhou, Shaoqing;
Petrossian, Albert;
Youniss, Fatma;
Sundaresan, Gobalakrishnan;
Wang, Li;
Zweit, Jamal;
Guruli, Georgi

Publication type:

Article

Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1919, doi. 10.1007/s00262-018-2166-4

By:

Pilatova, Katerina;
Bencsikova, Beatrix;
Demlova, Regina;
Valik, Dalibor;
Zdrazilova-Dubska, Lenka

Publication type:

Article

Cystatin F as a regulator of immune cell cytotoxicity.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1931, doi. 10.1007/s00262-018-2165-5

By:

Kos, Janko;
Nanut, Milica Perišić;
Prunk, Mateja;
Sabotič, Jerica;
Dautović, Esmeralda;
Jewett, Anahid

Publication type:

Article

Personalized cancer vaccines: adjuvants are important, too.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1911, doi. 10.1007/s00262-018-2158-4

By:

Gouttefangeas, Cécile;
Rammensee, Hans-Georg

Publication type:

Article

Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1897, doi. 10.1007/s00262-018-2157-5

By:

Rojas-Sepúlveda, Daniel;
Tittarelli, Andrés;
Gleisner, María Alejandra;
Ávalos, Ignacio;
Pereda, Cristián;
Gallegos, Iván;
González, Fermín Eduardo;
López, Mercedes Natalia;
Butte, Jean Michel;
Roa, Juan Carlos;
Fluxá, Paula;
Salazar-Onfray, Flavio

Publication type:

Article

Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1885, doi. 10.1007/s00262-018-2132-1

By:

Haeryfar, S. M. Mansour;
Shaler, Christopher R.;
Rudak, Patrick T.

Publication type:

Article

Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1871, doi. 10.1007/s00262-017-2104-x

By:

Shemesh, Avishai;
Brusilovsky, Michael;
Kundu, Kiran;
Ottolenghi, Aner;
Campbell, Kerry S.;
Porgador, Angel

Publication type:

Article

Cancer vaccine strategies: translation from mice to human clinical trials.

Published in:

Cancer Immunology, Immunotherapy, 2018, v. 67, n. 12, p. 1863, doi. 10.1007/s00262-017-2084-x

By:

Berzofsky, Jay A.;
Terabe, Masaki;
Trepel, Jane B.;
Pastan, Ira;
Stroncek, David F.;
Morris, John C.;
Wood, Lauren V.

Publication type:

Article